SPRIG Equity Closes Inaugural Fund with $50 Million AUM
SPRIG Equity, a prominent growth equity and late-stage venture capital firm, announces the successful closing of its inaugural fund, SPRIG Equity Fund I, with $50 million in assets under management. This venture emphasizes the firm's commitment to enhancing patient care through investments in transformative medical technologies.
Located in the bustling areas of Chicago and Orange County, SPRIG Equity focuses on identifying innovative breakthroughs across the medical technology spectrum. This includes a variety of sectors such as medical devices, diagnostics, and tech-enabled services that positively impact patient outcomes.
Managing Partner and Co-Founder Evan Norton expressed pride in this achievement, especially considering the competitive landscape for first-time funds. "In a year when such funds comprised just 6% of closures, our success highlights the strength of our investment strategy and our team's proficiency in sourcing quality deals that can elevate patient care while achieving impressive financial returns," he remarked.
The leadership team at SPRIG Equity is distinguished, with Evan Norton's robust background leading Abbott's corporate venture group, coupled with the expertise of co-founder Rebecca Raabe, a seasoned MedTech investor. Additionally, Katie Arnold, who is at the helm of SPRIG Consulting, brings extensive knowledge in medical technology commercialization. The firm also benefits from its dedicated advisory board, which consists of industry veterans and thought leaders.
A unique aspect of SPRIG Equity's operations is its access to exclusive off-market deal flow through its affiliation with SPRIG Consulting. This competitive edge is instrumental in their investment strategy.
Investments Already Making an Impact
SPRIG Equity has shown significant momentum in its investment strategy, having made four key portfolio investments. Each of these companies reflects the innovative spirit that SPRIG seeks in revolutionary medical technologies.
SetPoint Medical
This company specializes in a pioneering neuromodulation therapy aimed at aiding patients with chronic autoimmune diseases. Their solutions are positioned to transform treatment modalities in this area.
Conformal Medical
Known for its advanced left atrial appendage occlusion technology, Conformal Medical is focused on stroke prevention, representing an essential advancement in cardiovascular care.
Pi-Cardia
This commercial-stage company taps into the structural heart market with its innovative leaflet modification technologies, demonstrating significant promise in improving heart health outcomes.
Cytovale
Offering rapid diagnostic technologies for sepsis, Cytovale's solutions are vital in emergency department settings, ensuring timely patient care and potentially saving lives.
About SPRIG Equity
SPRIG Equity is dedicated to enhancing patient outcomes through strategic investments in the medical technology sector. Formed in 2023, the firm actively seeks late-stage opportunities and has a track record of supporting pioneering companies in the industry. Their portfolio includes notable names like Affera, NeuroPace, and Vertos, showcasing their commitment to making a significant impact in healthcare.
Frequently Asked Questions
What is SPRIG Equity Fund I?
SPRIG Equity Fund I is the inaugural fund launched by SPRIG Equity, focusing on transformative medical technologies with a total of $50 million in assets under management.
What does SPRIG Equity aim to achieve?
SPRIG Equity aims to improve patient outcomes by investing in innovative healthcare solutions and supporting best-in-class teams in the medical technology space.
Who are the key leaders at SPRIG Equity?
The firm is led by Managing Partner Evan Norton, co-founder Rebecca Raabe, and CEO Katie Arnold, all of whom have extensive backgrounds in the medical technology sector.
What industries does SPRIG Equity invest in?
SPRIG Equity primarily invests in sectors including medical devices, diagnostics, and tech-enabled services, all aimed at improving patient care.
How does SPRIG Equity stand out from its peers?
SPRIG Equity distinguishes itself through its proprietary deal sourcing and exclusive relationships that provide unique access to off-market investment opportunities.
